Today: 20 May 2026
Browse Category

NASDAQ:UNH 26 September 2025 - 6 February 2026

UnitedHealth stock slips after hours — here’s what could move UNH next

UnitedHealth stock slips after hours — here’s what could move UNH next

UnitedHealth shares fell 2.7% to $268.55 Thursday, with little change after hours, as investors reacted to Medicare Advantage reimbursement proposals. The Centers for Medicare & Medicaid Services set a Feb. 25 comment deadline and will announce final 2027 rates by April 6. UnitedHealth projected 2026 revenue above $439 billion, down from 2025 estimates. CEO Tim Noel called the proposed rate “disappointing.”
6 February 2026
Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

The Dow Jones rose 0.6% to 49,403 Monday afternoon, led by Apple and Cisco, while UnitedHealth and 3M lagged. Gold and silver hit new records as the dollar weakened. The Federal Reserve begins a two-day meeting Tuesday, with rates expected to hold steady. Investors await earnings from major tech firms and the Fed’s decision Wednesday.
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Plus Therapeutics’ CNSide Diagnostics signed a national agreement with UnitedHealthcare to cover its CNSide tumor cell test, effective Sept. 15, potentially reaching over 51 million members. PSTV shares surged about 60% premarket on Sept. 25 after the news. CNSide’s Houston lab secured CLIA accreditation the prior week. Plus Therapeutics also received $1.9 million in non-dilutive funding from CPRIT on Sept. 22.

Stock Market Today

  • LuxExperience B.V Q3 Loss Challenges Durable Profitability Narrative
    May 19, 2026, 11:01 PM EDT. LuxExperience B.V (NYSE:LUXE) reported Q3 2026 revenue of €618.5 million but posted a basic EPS loss of €0.22, wider than last year's loss of €0.06. Despite a five-year average EPS growth of 79.1%, net income swung from a €603.7 million profit in Q4 2025 to losses in recent quarters, highlighting volatility. The trailing twelve-month EPS stands at €3.46 on revenue of €2.4 billion. Shares trade at a low 1.7x price-to-earnings ratio versus 13x peers, reflecting market caution amid expected earnings decline of 78.1% annually over three years. Investors are wary of non-cash factors inflating reported profitability, questioning the sustainability of margins and cash generation. The Q3 loss challenges bullish views on consistent earnings resilience and long-term profitability for LuxExperience.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Go toTop